Abstract
Generic medicinal products, because of their ‘essential similarity’, are therapeutically interchangeable with brand-name products and represent an appealing alternative for National Health Services to control rising expenditure. Therapeutic equivalence is guaranteed by bioequivalence testing.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
